Millennium Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Millennium Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-629,300	Closed	-$24.8M	–	6866
2023 Q2	$24.8M	Buy	+629,300	New	+$22.2M	0.01%	1221
2022 Q4	–	Sell	-234,200	Closed	-$4.2M	–	7316
2022 Q3	$4.2M	Buy	+234,200	New	+$3.07M	﹤0.01%	3064
2022 Q1	–	Sell	-50,000	Closed	-$836K	–	7801
2021 Q4	$836K	Buy	+50,000	New	+$820K	﹤0.01%	4572
2017 Q1	–	Sell	-243,600	Closed	-$1.18M	–	3945
2016 Q4	$1.18M	Buy	+243,600	New	+$7.23M	﹤0.01%	2157
2014 Q2	–	Sell	-20,100	Closed	-$717K	–	4007
2014 Q1	$717K	Buy	+20,100	New	+$678K	﹤0.01%	2422

Millennium Management's ISEE Position: Q3 2023 in Review

Millennium Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 3,959,870 shares — an estimated $156M sold.

Millennium Management first reported a position in ISEE in Q4 2013 and held it in 36 quarters. The position peaked at $156M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Millennium Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 3,959,870 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $156M.
Millennium Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
Millennium Management's IVERIC bio, Inc. Common Stock position peaked at $156M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.